Cytotoxic T-lymphocyte epitopes for HLA-B53 and other HLA types in the malaria vaccine candidate liver-stage antigen 3

Infection and Immunity

Volumn 68, Issue 1, 2000, Pages 227-232

  Aidoo, Michael ^a,f   Lalvani, Ajit ^a   Gilbert, Sarah C ^b   Hu, Jiang Ting ^b   Daubersies, Pierre ^c   Hurt, Nicole ^d   Whittle, Hilton C ^e   Druihle, Pierre ^c   Hill, Adrian V S ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c INSTITUT PASTEUR   (France)

^d NATIONAL INSTITUTE OF MEDICAL RESEARCH   (Tanzania)

^e MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^f NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; EPITOPE; HLA ANTIGEN; MALARIA VACCINE;

ANTIGEN SPECIFICITY; ARTICLE; CYTOTOXIC T LYMPHOCYTE; HLA SYSTEM; HUMAN; HUMAN CELL; MALARIA; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VACCINATION;

EID: 0033960941     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.1.227-232.2000     Document Type: Article

References (30)

1. Aidoo, M., A. Lalvani, C. E. Allsopp, M. Plebanski, S. J. Meisner, P. Krausa, M. Browning, S. Morris Jones, F. Gotch, D. Fidock, M. Takiguchi, K. J. Robson, B. M. Greenwood, P. Druilhe, H. C. Whittle, and A. V. S. Hill. 1995. Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria. Lancet 345:1003-1007.
2. Aidoo, M., A. Lalvani, H. C. Whittle, A. V. Hill, and K. J. Robson. 1997. Recombinant vaccinia viruses for the characterization of Plasmodium falciparum-specific cytotoxic T lymphocytes: recognition of processed antigen despite limited re-stimulation efficacy. Int. Immunol. 9:731-737.
3. BenMohamed, L., H. Gras-Masse, A. Tartar, P. Daubersies, K. Brahimi, M. Bossus, A. Thomas, and P. Druilhe. 1997. Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees. Eur. J. Immunol. 27:1242-1253.
4. Blum-Tirouvanziam, U., C. Servis, A. Habluetzel, D. Valmori, Y. Men, F. Esposito, L. Del Nero, N. Holmes, N. Fasel, and G. Corradin. 1995. Localization of HLA-A2.1-restricted T cell epitopes in the circumsporozoite protein of Plasmodium falciparum. J. Immunol. 154:3922-3931.
5. Doolan, D. L., R. C. Hedstrom, W. O. Rogers, Y. Charoenvit, M. Rogers, P. de la Vega, and S. L. Hoffman. 1996. Identification and characterization of the protective hepatocyte erythrocyte protein 17 kDa gene of Plasmodium yoelii, homolog of Plasmodium falciparum exported protein 1. J. Biol. Chem. 271:17861-17868.
6. Doolan, D. L., S. L. Hoffman, S. Southwood, P. A. Wentworth, J. Sidney, R. W. Chesnut, E. Keogh, E. Appella, T. B. Nutman, A. A. Lal, D. M. Gordon, A. Oloo, and A. Sette. 1997. Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. Immunity 7:97-112.
7. Doolan, D. L., R. A. Houghten, and M. F. Good. 1991. Location of human cytotoxic T cell epitopes within a polymorphic domain of the Plasmodium falciparum circumsporozoite protein. Int. Immunol. 3:511-516.
8. Doolan, D. L., M. Sedegah, R. C. Hedstrom, P. Hobart, Y. Charoenvit, and S. L. Hoffman. 1996. Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ T cell-, interferon γ-, and nitric oxide-dependent immunity. J. Exp. Med. 183:1739-1746.
9. Elvin, J., V. Cerundolo, T. Elliott, and A. A. Townsend. 1991. A quantitative assay of peptide-dependent class I assembly. Eur. J. Immunol. 21:2025-2031.
10. Gilbert, S. C., M. Plebanski, S. J. Harris, C. E. Allsopp, R. Thomas, G. T. Layton, and A. V. S. Hill. 1997. A protein particle vaccine containing multiple malaria epitopes. Nat. Biotechnol. 15:1280-1284.
11. Hill, A. V., C. E. Allsopp, D. Kwiatkowski, N. M. Anstey, P. Twumasi, P. A. Rowe, S. Bennett, D. Brewster, A. J. McMichael, and B. M. Greenwood. 1991. Common west African HLA antigens are associated with protection from severe malaria. Nature 352:595-600.
12. Hill, A. V., J. Elvin, A. C. Willis, M. Aidoo, C. E. Allsopp, F. M. Gotch, X. M. Gao, M. Takiguchi, B. M. Greenwood, A. R. Townsend, A. J. McMichael, and H. C. Whittle. 1992. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 360:434-439.
13. Hoffman, S. L., E. D. Franke, M. R. Hollingdale, and P. Druilhe. 1997. Attacking the infected hepatocyte, p. 35-76. In S. L. Hoffman (ed.), Malaria vaccine development. American Society for Microbiology, Washington, D.C.
14. Hope, I. A., R. Hall, D. L. Simmons, J. E. Hyde, and J. G. Scaife. 1984. Evidence for immunological cross-reaction between sporozoites and blood stages of a human malaria parasite. Nature 308:191-194.
15. Lalvani, A., R. Brookes, S. Hamblelon, W. J. Britton, A. V. Hill, and A. J. McMichael. 1997. Rapid effector function in CD8+ memory T cells. J. Exp. Med. 186:859-865.
16. Lalvani, A., R. Brookes, R. J. Wilkinson, A. S. Malin, A. A. Pathan, P. Andersen, H. Dockrell, G. Pasvol, and A. V. S. Hill. 1998. Human cytolytic and interferon γ-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 95:270-275.
17. Lalvani, A., N. Hurt, M. Aidoo, P. Kibatala, M. Tanner, and A. V. S. Hill. 1996. Cytotoxic T lymphocytes to Plasmodium falciparum epitopes in an area of intense and perennial transmission in Tanzania. Eur. J. Immunol. 26:773-779.
18. Marchand, C., and P. Druilhe. 1990. How to select P. falciparum antigens in an expression library without defined probe. Bull. W. H. O. 68:158-164.
19. McAdam, S., P. Klenerman, L. Tussey, S. Rowland Jones, D. Lalloo, R. Phillips, A. Edwards, P. Giangrande, A. L. Brown, F. Gotch, and A. J. McMichael. 1995. Immunogenic HIV variant peptides that bind to HLA-B8 can fail to stimulate cytotoxic T lymphocyte responses. J. Immunol. 155: 2729-2736.
20. Nardin, E. H., and R. S. Nussenzweig. 1993. T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages. Annu. Rev. Immunol. 11:687-727.
21. Plebanski, M., M. Aidoo, H. C. Whittle, and A. V. S. Hill. 1997. Precursor frequency analysis of cytotoxic T lymphocytes to pre-erythrocytic antigens of Plasmodium falciparum in West Africa. J. Immunol. 158:2849-2855.
22. Rammensee, H. G., T. Friede, and S. Stevanovich. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics 41:178-228.
23. Renggli, J., M. Hahne, H. Matile, B. Betschart, J. Tschopp, and G. Corradin. 1997. Elimination of P. berghei liver stages is independent of Fas (CD95/ Apo-I) or perforin-mediated cytotoxicity. Parasite Immunol. 19:145-148.
24. Sanchez, G. I., W. O. Rogers, S. Mellouk, and S. L. Hoffman. 1994. Plasmodium falciparum: exported protein-1, a blood stage antigen, is expressed in liver stage parasites. Exp. Parasitol. 79:59-62.
25. Schofield, L., J. Villaquiran, A. Ferreira, H. Schellekens, R. Nussenzweig, and V. Nussenzweig. 1987. Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature 330:664-666.
26. Sedegah, M., B. K. Sim, C. Mason, T. Nutman, A. Malik, C. Roberts, A. Johnson, J. Ochola, D. Koech, B. Were, and S. L. Hoffman. 1992. Naturally acquired CD8+ cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein. J. Immunol. 149:966-971.
27. White, K. L., H. L. Snyder, and U. Krzych. 1996. MHC class I-dependent presentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for protective immunity against Plasmodium berghei. J. Immunol. 156:3374-3381.
28. Wizel, B., R. Houghten, P. Church, J. A. Tine, D. Lanar, D. M. Gordon, W. R. Ballou, A. Sette, and S. L. Hoffman. 1995. HLA-A2-restricted cytotoxic T lymphocyte responses to multiple Plasmodium falciparum sporozoite surface protein 2 epitopes in sporozoite-immunized volunteers. J. Immunol. 155: 766-775.
29. Wizel, B., R. A. Houghten, K. C. Parker, J. E. Coligan, P. Church, D. M. Gordon, W. R. Ballou, and S. L. Hoffman. 1995. Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2. J. Exp. Med. 182:1435-1445.
30. Yang, C., Y. P. Shi, V. Udhayakumar, M. P. Alpers, M. M. Povoa, W. A. Hawley, W. E. Collins, and A. A. Lal. 1995. Sequence variations in the non-repetitive regions of the liver stage-specific antigen-1 (LSA-1) of Plasmodium falciparum from field isolates. Mol. Biochem. Parasitol. 71:291-294.